ESC 365 - A randomised trial of transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation: TRISCEND II trial

ESC Professional Premium Access

A randomised trial of transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation: TRISCEND II trial

Session: The year in review: top trials in structural interventions impacting guidelines and patient care

Topic: Interventional Cardiology

Speaker: Doctor J. Granada (New York, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Juan Granada

Columbia Presbyterian Hospital, New York (United States of America)

3 presentations

0 follower

4 more presentations in this session

Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus: the SMART trial

Speaker: Associate Professor A. Petronio (Pisa, IT)

Transcatheter or surgical treatment of aortic-valve stenosis: the DEDICATE-DZHK6 trial

Speaker: Professor T. Rudolph (Bad Oeynhausen, DE)

1-year outcomes from the CLASP IID randomised trial for degenerative mitral regurgitation

Speaker: Doctor M. Guerrero (Rochester, US)

The year in review: top trials in structural interventions impacting guidelines and patient care - discussion

Access the full session

The year in review: top trials in structural interventions impacting guidelines and patient care

Speakers: Doctor J. Granada, Associate Professor A. Petronio, Professor T. Rudolph, Doctor M. Guerrero

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources